The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I think sphinx is correct that the sentiment has been a fear of a fundraising for a long time now, causing those who would consider buying more shares to pause. In the main, this is countered by a very small amount of sellers. An illiquid share trade situation doesn't do anyone a favour, This stasis has to be broken, either by the aforesaid cash raise, or by one of several other potential funding arrangements being announced. It's more that obvious that substantial sales to high credit rated clients would be relatively easy to insure by invoice discounting, credit finance, overdraft, export credit guarantee, factoring, blah blah. More than one way? That's an understatement, but certainty wouldn't half be useful to us holders to know.
With possible vast expansion of volume probable upon passing regulations in China, Mr Ford will have had funding that right at the top of his agenda. The opinion of a miniscule holding failed investor venting his spleen on a chat board isn't worth his time reading, that's for sure.
The webinar is explaining the seismic date, which has been validated by the drills so far, presented by the geologist who has a vast amount of experience and knowledge of the terrain. There ARE billions of barrels of oil in that domain.
Utterly dishonest to describe the acquisition of billions of barrels of oil as "hot air"
It is a material change in the potential value of the company..
If you're in to correlations, why is it that when you, in all your ID's, claim a drastic fall is coming, the sp rises strongly soon after. If you are trying to keep the shorter solvent, you'd be better shutting up.
Official, 19th Oct RNS
he plan targets FID (final investment decision) by the end of 2025 with first production to follow in early 2026. Estimated costs to first production are conservatively estimated at $120 million, based on:
· $20 million for the hot tap
· $20 million for facilities upgrade (including preparing Alkaid-2 for injection service)
· $60 million for the first three production wells
· $20 million for three years of corporate G&A
This cost to reach first production contrasts with other developments in the region, requiring at least an order of magnitude greater expenditure. Additional development costs after first production are expected to be funded through debt or equivalent sources. The Company will provide further updates on its financing activities, designed to minimize equity or other value dilution for existing investors, as arrangements progress.
In order to achieve the stated goals, insti investors will be needed. This appointment facilitates that. It also make a US market listing more likely.
Anyone that suggests it is anything but a positive move is spreading lies.
The Louis/kever/rogadar multi ID tactics are purely an attempt to dissuade potential buyers in order to mitigate losses for shorters. Who's to say they won't succeed. The plan laid out by the company requires patience, something often lacking in PI's. I'll be adding more, but judging timing isn't easy, because we've all had the heads up that funding agreements could drop at any time. DH has said that their priority is to protect the shareholders interests, and his skin in the game is proof that he means just that.
Even a beginner knows that it isn't what you buy shares at, it's what you sell them at.
And you would think that even the multi ID ex Louis bashers would see that.
But then, they are talking someone else's short.
Not correct Louis 11
Holders know what is going on, having been fully informed by an excellent webinar, Talks over financing don't get concluded overnight, but the resource is too important to US fuel security, in US territory in an area with strong regulatory support, close to existing infrastructure, to be held up for long.
As DH said, this is an opportune time to add, or, in your master's case, close shorts
Exactly, they've got all the right contacts. Retailers want generic support adverts to drive customers to their shelves If DSM can prove up the gut health aspect, it becomes a direct competitor with the major yoghurt drinks. But only if folks get to know about it.
It's a job that they should have done when application to trade shares was received. Their answer should have been " No, you can not demonstrate solvency." To my mind, FCA have been less than useless, although eventually they manage to convict. Financially, that's of no use to the folks parted from their funds.